Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,013 | 32,325 | 37,633 | 42,755 | 38,642 |
| Marketable Securities | 8,545 | 21,541 | 23,960 | 22,609 | 31,448 |
| Receivables | 2,898 | 2,932 | 2,007 | 2,503 | 2,803 |
| Inventories | 172 | 92 | N/A | N/A | N/A |
| TOTAL | $47,628 | $56,890 | $63,600 | $67,867 | $72,893 |
| Non-Current Assets | |||||
| PPE Net | 2,395 | 2,073 | 2,127 | 2,105 | 2,084 |
| Investments And Advances | 25 | 25 | 25 | 12 | 10 |
| Intangibles | 14,872 | 15,207 | 15,442 | 15,677 | 15,909 |
| Other Non-Current Assets | 1,961 | 2,109 | 2,195 | 1,876 | 1,882 |
| TOTAL | $19,253 | $19,414 | $19,789 | $19,670 | $19,885 |
| Total Assets | $66,881 | $76,304 | $83,389 | $87,537 | $92,778 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,419 | 2,982 | 3,103 | 2,154 | 2,017 |
| Accrued Expenses | 2,656 | 2,662 | 2,361 | 2,217 | 2,397 |
| Other current liabilities | 126 | 89 | 150 | 144 | 144 |
| TOTAL | $6,282 | $6,882 | $6,541 | $5,326 | $5,342 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 115 | 175 | N/A | 26 | 26 |
| Other Non-Current Liabilities | 6,699 | 6,715 | 6,821 | 6,256 | 5,850 |
| TOTAL | $5,868 | $6,002 | $6,088 | $5,568 | $5,332 |
| Total Liabilities | $12,150 | $12,884 | $12,629 | $10,894 | $10,674 |
| Shareholders' Equity | |||||
| Common Shares | 234 | 234 | 234 | 231 | 230 |
| Retained earnings | -215,344 | -207,069 | -199,698 | -192,088 | -185,878 |
| Other shareholders' equity | 9,200 | 9,767 | 10,068 | 10,242 | 10,568 |
| TOTAL | $54,731 | $63,420 | $70,760 | $76,643 | $82,104 |
| Total Liabilities And Equity | $66,881 | $76,304 | $83,389 | $87,537 | $92,778 |